Table 2 JAK1 frame-shift truncating mutation in TCC tumors and matched normal tissues+

From: JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations

Barcode

JAK1 mutation (TCC)

Mutation allele fraction (TCC)

Primary tissue

ID

JAK1 mutation in tumor (Sanger Sequencing)

Matched normal tissue

ID

JAK1 mutation in normal tissue (Sanger Sequencing)

DS-58859

K860fs

0.85

Endometrium

1T

mut

N/A

N/A

N/A

DS-57828

K860fs

0.53

Endometrium

2T

mut

Endometrium

2N

wt

DS-55004

K142fs; K860fs

0.19; 0.60

Uterus**

3T

K142wt; K860mut

Uterus

3N

wt

DS-60386

K860fs

0.45

Endometrium*

4T

mut

Large Bowel

4N

wt

DS-55027

R174X

0.42

Uterus**

5T

mut

Uterus

5N

wt

DS-55352

P430fs

0.31

Uterus**

6T

mut

Uterus

6N

wt

DS-80370

K142fs; P430fs

0.37; 0.26

Endometrium

7T

K142mut; P430mut

Endometrium

7N

wt

  1. +Mut, mutation; wt, wildtype.
  2. *Tumor tissue collected from metastatic tumor in vagina.
  3. **Adenocarcinoma.